PharmaVOICE’s Pulse Report: Decentralized Clinical Trials pulls together industry leaders, including AiCure CEO Edward Ikeguchi, to weigh in on the current state of decentralized clinical trials as well as what the future may hold.
-
Share
-
Recent Press
-
Jul 29, 2026
AICure Expands Executive Leadership to Accelerate AI-Powered Medication Adherence, Remote Weight Verification, and Enterprise White-Label Solutions
-
Jul 21, 2026
Forbes: The AI Company Transforming Medication Adherence And Weight Loss
-
May 29, 2025
AiCure Appoints Sabina Chadha as CEO, Ed Ikeguchi Transitions to Chief Medical Officer, and Josh Wilson Promoted to COO and President
-
Jul 29, 2026